Health Condition 1: Z733- Stress, not elsewhere classified
Conditions
Sponsors
Dr Mansee Thakur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy volunteers with no history of bacterial/viral/fungal infections from the past two months. 2. None of the participants should have any prior experience of practice in any meditation technique.
Exclusion criteria
Exclusion criteria: 1. The volunteers with a lifetime history of psychosis, bipolar disorder, major depressive disorder, substance abuse or dependence, a significant head injury, a seizure disorder, mental retardation, autoimmune disorders, immunodeficiency disorders and neurological disorders. 2. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mean Perceived Stress Score 2. Mean Maslach Burnout Inventory (MBI) Score 3. Mean World Health Organization- Well-being Index (WHO-WBI) Score 4. Serum Cortisol/MDA/Nitrate levels 5. T cell immune response and cytokine secretion profileTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To understand the immunomodulatory function of Heartfulness meditation via the activation of CD3/28 pathways and the cytokine secretion levels after meditation. 2. Development of Process and Protocols for Reliable Measurements of immunomodulation of T Helper cell Using Flow Cytometry. 3. To provide scientific data to demonstrate that the immune system can be voluntarily influenced by non-pharmaceutical interventions like Heartfulness Meditation. 4. It will also aid in achieving the main vision of “WHO Special Initiative for Mental Health 2019-2023 ? ie. to provide highest standard of mental health and well-being. 5. Meditation as a behavioral intervention will be used as a preventive measure to improve mental health and well-being. Timepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactMs. Sanjana T. Philip
MGMSBS, MGMIHS
Outcome results
None listed